AVIR

AVIR Operating Income Growth

-17.24%TTM

Period ending:

AVIR TTM Operating Income YoY %%
AVIR TTM Operating Income YoY %1594.05%-880.89%
2020-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

AVIR operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 23 observations from Dec 31, 2020 to Jun 30, 2026.

Atea Pharmaceuticals Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
-17.236%
-17.0601%
6.2519%
17.715%
23.2585%
15.7038%
-17.5363%
-27.3094%
-53.4621%
-47.9492%
-25.6502%
-617.5419%
-641.3776%
-298.4011%
-194.4167%
-19.5867%
-42.0113%
176.9159%
1,354.5422%
203.8873%
287.716%
245.3842%
24.4934%

Compare operating income growth

All AVIR financial metrics · AVIR stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.